The major objective of this proposal is the total synthesis of the antibiotic, thermorubin. A synthetic plan is outlined. Secondary objectives are (a) the synthesis of sample homologs of thermorubin with a view to defining the pharmacophoric group of the molecule and (b) the pursuit of a lead that should allow solubilization of the molecule for systemic use. The total synthesis studies should be materially aided by the work on the sample homologs. Thermorubin is a potent antibiotic comparable to penicillin G in biological activity whose only drawback is its poor solubility in physiological fluids. It is low in mammalian toxicity and has no cross-resistance with other antibiotics. Its mechanism of action-inhibition of initiation of protein synthesis is different from known antibacterial agents. Therefore from the point of view of health-related objectives we believe it merits attention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI019709-03
Application #
3129079
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1983-01-01
Project End
1986-07-31
Budget Start
1985-01-01
Budget End
1986-07-31
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794